MedPath

Outcome of Emicizumab Prophylaxis in Patients of Haemophilia A with or without Inhibitor An interventional study

Phase 4
Conditions
Health Condition 1: D66- Hereditary factor VIII deficiency
Registration Number
CTRI/2024/08/071826
Lead Sponsor
ESIPGIMSR ESIC Medical College and Hospital Joka Kolkata
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All patients having severe Haemophilia A and moderate Haemophilia A with bleeding phenotype with or without inhibitor are included in the study

Exclusion Criteria

Haemophilia B patients and patients of other coagulation disorders are excluded from the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath